• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Quantitative Determination of the Surfactant-Induced Split Ratio of Influenza Virus by Fluorescence Spectroscopy

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2016 Feb 22:0. [Epub ahead of print]
[h=1]Quantitative Determination of the Surfactant-Induced Split Ratio of Influenza Virus by Fluorescence Spectroscopy.[/h] Lee KK[SUP]1[/SUP], Sahin YZ[SUP]1[/SUP], Neeleman R[SUP]2[/SUP], Trout BL[SUP]3[/SUP], Kayser V[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The majority of marketed seasonal influenza vaccines are prepared using viruses that are chemically inactivated and treated with a surfactant. Treating with surfactants has important consequences: it produces 'split viruses' by solubilizing viral membranes, stabilizes free membrane proteins and ensures a low level of reactogenicity while retaining high vaccine potency. The formulation stability and potency of split influenza vaccines are largely determined by the specifics of this 'splitting' process; namely, the consequent conformational changes of proteins and interactions of solubilized particles, which may form aggregates. Robust methods to quantitatively determine the split ratio need to be developed before optimal splitting conditions can be investigated to streamline production of superior influenza vaccines. Here, we present a quantitative method, based on both steady-state and time-resolved fluorescence spectroscopy, to calculate the split ratio of the virus after surfactant treatment. We use the lipophilic dye Nile Red (NR) as a probe to elucidate molecular interactions and track changes in molecular environments. Inactivated whole influenza viruses obtained from a sucrose gradient were incubated with NR and subsequently treated with increasing concentrations of the surfactant Triton X-100 (TX-100) to induce virus splitting. NR's emission spectra showed that the addition of TX-100 caused ?27 nm red-shifts in the emission peak, indicative of increasingly hydrophilic environments surrounding NR. The emission spectra of NR at different surfactant concentrations were analyzed with multi-peak fitting to ascertain the number of different micro-environments surrounding NR and track its population change in these different environments. Results from both the emission spectra and fluorescence lifetime spectroscopy revealed that NR showed presence in three distinct molecular environments. The split ratio of the virus was then calculated from the percentages of NR in these environments using both fluorescence emission and lifetime data. This study can pave the way for the development of robust methods to rapidly quantify splitting extent during vaccine manufacturing.


[h=4]KEYWORDS:[/h] Influenza virus; Nile Red; Triton X-100; fluorescence emission; fluorescence lifetime; influenza split virus vaccine; membrane-surfactant interactions; partitioning of dye in membranes; protein aggregation; split ratio quantification; surfactant; vaccine formulation; vaccine manufacturing; virus splitting; virus-surfactant interactions

PMID: 26901837 [PubMed - as supplied by publisher]
 
Back
Top Bottom